Report #2859263

Received Sep 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: AR
Recovered: Unknown
Vaccinated: Jul 22, 2025
Onset: Sep 8, 2025
Days to onset: 48
Hospital days: —

Vaccines (2)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (RECOMBIVAX HB)	MERCK & CO. INC.	1	—	—
HEP	HEP B (RECOMBIVAX HB)	MERCK & CO. INC.	2	—	—

Symptoms (2)

Inappropriate schedule of product administrationNo adverse event

Symptom narrative

No adverse effects were reported; RECOMBIVAX HB 15 days late / First dose was given on 7/22/2025 and the second dose was administered on 9/8/2025; This spontaneous report was received from a pharmacist and refers to an 18-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 22-Jul-2025, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB),, dose number 1, (lot # and expiration date were not reported). On 08-Sep-2025, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB), dose number 2, (lot # and expiration date were not reported) as a prophylaxis. However, the 2 dose was 15 days late (inappropriate schedule of vaccine administrated). No adverse effects were reported.